MorphoSys publications

A selection of published literature, describing the cutting-edge advances which MorphoSys’s technologies and products are based on.



  1. Molecular basis of in vitro affinity maturation and functional evolution of a neutralizing anti-human GM-CSF antibody
    Eylenstein, R; et al mAbs
  2. Solution Equilibrium Titration for High-
    Della Ducata, D; Journal of Biomolecular Screening 2015, Vol. 20(10)


  1. "Characterization and screening of IgG binding to the neonatal Fc receptor"
    Neuber, T. et al.; MAbs. 2014 Jul 1;6(4). [Epub ahead of print]
  2. MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial
    Behrens, F; et al. Ann Rheum Dis 2014


  1. "A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties"
    Tiller, T. et al.; MAbs. 2013 Apr 9;5(3). [Epub ahead of print]
  2. "An automated immunoassay for early specificity profiling of antibodies"
    Frese, K. et al.; MAbs. 2013 Feb 14;5(2). [Epub ahead of print]


  1. "Granulocyte macrophage-colony stimulating factor is a key mediator in experimental osteoarthritis pain and disease development"
    Cook, AD. et al,; Arthrithis research & therapy, Epub 2012 Sep 20
  2. "Granulocyte-macrophage colony-stimulating factor is a key mediator in inflammatory and arthritic pain"
    Cook, AD. et al.; Annals of the rheumatic diseases, Epub 2012 Jul 24
  3. "Phage Display"
    Petropoulos, K.; Methods in Molecoular Biology, Epub 2012 June
  4. "Evaluation of combination therapies with MOR00208, an Fc-enhanced humanized CD19 antibody, in models of lymphoma"
    Winderlich, M. et al; Presentation given at the 2012 ASCO Annual Meeting, Jun 1-5; citation: Journal of Clinical Oncology 30: 2012 (suppl; abstr 6574)


  1. "Gantenerumab: A Novel Human Anti-Aβ Antibody Demonstrates Sustained Cerebral Amyloid-β Binding and Elicits Cell-Mediated Removal of Human Amyloid-β"
    Bohrmann, B. et al; Journal of Alzheimer's Disease, Epub 2011 Sep 28
  2. "Antibodies in Metabolic Diseases"
    Ahrens, B.; New Biotechnology, 2011 Sep, 28 (5)
  3. "HuCAL PLATINUM, a Synthetic Fab Library Optimized for Sequence Diversity and Superior Performance in Mammalian Expression Systems"
    Prassler, J. et al; Journal of Molecular Biology, Epub 2011 Aug 12
  4. "Synthetic Antibodies Designed on Natural Sequence Landscapes"
    Zhai, W. et al.; Journal of Molecular Biology, Epub 2011 Jul 23
  5. "Effect of MOR202, a human CD38 antibody, in combination with lenalidomide and bortezomib, on bone lysis and tumor load in a physiologic model of myeloma"
    Endell, J. et al.; Presentation given at the 2011 ASCO Annual Meeting, Jun 3-7; citation: Journal of Clinical Oncology 29: 2011 (suppl; abstr 8078)